Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER

HER-2 Positive Breast Cancer

National Taiwan University Hospitalmonoclonal_antibodyPhase 3Active
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
89/ 100

Competitive context

11 Active assets in the HER-2 Positive Breast Cancer cohort.

Asset / SponsorPhaseRating
TRASTUZUMAB
National Taiwan University Hospital
Phase 3BB
Carboplatin
Instituto do Cancer do Estado de São Paulo
Phase 2/3BB
Letrozole
Alliance Foundation Trials, LLC.
Phase 3BB
Trastuzumab Emtansine
Dana-Farber Cancer Institute
Phase 2/3BB
Inno-206
National Taiwan University Hospital
Phase 2BB

View all 25 →

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER is also rated in:

breast carcinomaDormant
BBB
Indicative ·
75 / 100
View asset →
inflammatory breast carcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
HER2 positive breast carcinomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →